Mounjaro outperforms Ozempic for weight loss, finds study
Mounjaro outperforms Ozempic in helping people lose weight, a new study shows.
Jul 8, 2024
0
17
Mounjaro outperforms Ozempic in helping people lose weight, a new study shows.
Jul 8, 2024
0
17
A seven-day, extended-release version of buprenorphine—a treatment for opioid use disorder (OUD) that can reduce opioid use and overdose deaths—is safe and effective for people with OUD experiencing minimal symptoms of ...
Jul 8, 2024
0
0
Policies designed to ensure Indigenous Australians have equitable access to medicines aren't being accessed uniformly across the nation, our research shows.
Jul 8, 2024
1
0
New research has demonstrated the effectiveness of a first-in-class oral, non-hormonal drug in increasing embryo implantation, pregnancy and live birth rates among infertile women who are undergoing in vitro fertilization ...
Jul 7, 2024
1
15
A class of diabetes medications, which include the best-selling drug Ozempic, are associated with a reduced risk of certain obesity-related cancers, according to a study released Friday.
Jul 6, 2024
0
138
Teams at two of Melbourne's leading research and medical institutes are developing high-tech solutions to rapidly test for drugs and better treat patients presenting to hospital.
Jul 5, 2024
0
0
Cancer's resistance to chemotherapy could be reversed by targeting lactate—the product that builds up as cancer cells convert nutrients to energy, according to new research published in Nature.
Jul 4, 2024
0
31
Only half (53%) of online advertisements for medicines are correctly categorized by consumers as legitimate or illicit. This result emerged from project CAPSULE, conducted by Transcrime, Joint Research Center of the Università ...
Jul 3, 2024
0
1
Twelve years ago, cancer researchers at University of California San Diego identified a molecule that helps cancer cells survive by shuttling damaging inflammatory cells into tumor tissue. In new research, they show that ...
Jul 3, 2024
0
5
The European Union has approved Sanofi and Regeneron's blockbuster drug Dupixent for the treatment of chronic obstructive pulmonary disease (COPD), the French pharmaceutical giant said on Wednesday.
Jul 3, 2024
0
0